Fergal O'Brien
Keine laufenden Positionen mehr
Profil
Fergal O'Brien worked as a Chief Executive Officer at Warwick Effect Polymers Ltd.
from 2004 to 2006.
He also held positions as a Director-Process Operations at Biocleave Ltd., and as a Principal at Celltech Group Plc, Groupe Bruxelles Lambert SA, Enzymatix Ltd., Chiroscience Group Plc, Dow Pharmaceutical Sciences, Inc., and Chirotech Technology Ltd.
Mr. O'Brien obtained an undergraduate degree from London Metropolitan University.
Ehemalige bekannte Positionen von Fergal O'Brien
Unternehmen | Position | Ende |
---|---|---|
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | Präsident | 01.01.2006 |
Biocleave Ltd.
Biocleave Ltd. BiotechnologyHealth Technology Biocleave Ltd. develops and sells microbial technology for the production of renewable chemicals and biofuels. It also provides biobutanol and other C4 chemical products. The firm also engages in microbiology and metabolic engineering through fermentation and commercial production scale. Its products include biobutanol chemicals and fuel, acetone, and butyric acid. The company was founded by Edward M. Green in 2003 and is headquartered in Abingdon, the United Kingdom. | Corporate Officer/Principal | - |
Enzymatix Ltd.
Enzymatix Ltd. Pharmaceuticals: OtherHealth Technology Enzymatix Ltd. makes pharmaceutical products. | Corporate Officer/Principal | - |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Corporate Officer/Principal | - |
GROUPE BRUXELLES LAMBERT SA | Corporate Officer/Principal | - |
Ausbildung von Fergal O'Brien
London Metropolitan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GROUPE BRUXELLES LAMBERT SA | Finance |
Private Unternehmen | 7 |
---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Enzymatix Ltd.
Enzymatix Ltd. Pharmaceuticals: OtherHealth Technology Enzymatix Ltd. makes pharmaceutical products. | Health Technology |
Chiroscience Group Plc | Commercial Services |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Distribution Services |
Biocleave Ltd.
Biocleave Ltd. BiotechnologyHealth Technology Biocleave Ltd. develops and sells microbial technology for the production of renewable chemicals and biofuels. It also provides biobutanol and other C4 chemical products. The firm also engages in microbiology and metabolic engineering through fermentation and commercial production scale. Its products include biobutanol chemicals and fuel, acetone, and butyric acid. The company was founded by Edward M. Green in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Chirotech Technology Ltd.
Chirotech Technology Ltd. Financial ConglomeratesFinance Chirotech Technology Ltd. was founded in 1991 and operates as a British dormant company. The company is based in Cambridge, UK. | Finance |
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | Process Industries |